ubmslateRN-logo-ubm

RN Mobile Menu

Topics:

Lupus

Monitoring Drug Levels Can Help Treatment Adherence

A Johns Hopkins rheumatologist speaks with RN about the importance of monitoring whole-blood hydroxychloroquine for treatment adherence in lupus.  
(©Photographee.eu/Shutterstock.com)

Lupus

Barbara Vilen, Ph.D.

In this Q&A, Rheumatology Network speaks with Dr. Barbara Vilen who is making strides in both basic and translational research that may lead to new therapeutic targets for lupus.

Stephen Katz M.D., Ph.D.

In this Q&A, Rheumatology Network speaks with Dr. Stephen Katz about the NIAMS Action Plan for Lupus Research.

 Michelle Petri, M.D.

Adherence to lupus treatment can be less than ideal, says Dr. Michelle Petri of Johns Hopkins. This is why monitoring whole-blood hydroxychloroquine levels is an important part of treatment.

Yehuda Shoenfeld, M.D.

In patients with CNS lupus, early evidence shows the presence of the development of dementia, says Dr. Yehuda Shoenfeld of Israel. "Lupus is a disease of young females, so it's not elderly females with dementia at this age."

©SoloviovaLiudmyla/Shutterstock.com

EULAR 2016: A new study shows an association between daily exposure to air pollutants and childhood-onset systemic lupus erythematous.

©gopixa/Shutterstock.com

Rheumatoid arthritis and lupus are distinct conditions that present in unique ways, but they do share various genetic risk factors.

Rituximab might even be effective for forms of Lupus that resist standard treatments.

Pages

Subscribe to Lupus on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.